Ho, J., Yang, O., Yu, N., Chang, C., Liu, C. (., Chiu, S., Tu, C., Chiang, H. C., Cho, D. (2026). A phase I/IIa dose-escalation, dose-optimization, and dose-expansion study to evaluate the safety and preliminary efficacy of tri-specific antibody (SOA101) in subjects with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2671